MRK241129P88000
- 0.04
- 0.000.00%
Merck & Co Newsroom
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Express News | The annual pharmaceutical imports value of Peking Tianzhu Comprehensive Bonded Zone is approximately 120 billion yuan.
The Trump economic team may have internal discord, and the key agenda still needs the "understanding king" to make the final decision!
Analysts state that the Trump team's characterization of the economic policy as 'the opponent team' is almost accurate, and the strong opposition between Besant and Lutnik has been publicly reported.
Express News | Merck's innovative drug, Tabrecta hydrochloride, has been included in the new national medical insurance list.
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study
Amgen, Boeing Share Losses Lead Dow's 200-Point Fall
Merck & Co. (MRK) Fell As It Faced Some Demand Headwinds In China
Daily short sale tracking: Nu Holdings's short volume increased by 25 million, with a short sale ratio of 31%
Nu Holdings(NU.US) ranked top of the list had the largest change in short volume (25.32 million shares), and the short volume ratio of QXO Inc(QXO.US) reached 44.93%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
Dr. Reddy's Laboratories Launches Anti-Parasitic Drug Ivermectin
Jefferies Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $150
Jefferies Reaffirms Their Buy Rating on Merck & Company (MRK)
Today's Analyst Rating | UnitedHealth Price Target Raised to $655 by RBC Capital, Citi Upgrades Chevron to Buy
Nov 26, Wall Street analysts have updated their stock ratings today including $UnitedHealth(UNH.US)$ and $Chevron(CVX.US)$.
Morgan Stanley Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $123
Merck & Co. Hold Rating: Balancing Promising Trial Results With Market Dynamics and Future Uncertainties
Merck's "first-in-class" therapy Winrevair (sotatercept) achieves Phase 3 clinical primary endpoints.
Winrevair is a first-in-class type II Activin receptor (ActRIIA) fusion protein.
BMO Capital Maintains Merck & Co(MRK.US) With Buy Rating, Cuts Target Price to $136
Nike, Sherwin-Williams Co. Share Gains Lead Dow's Nearly 250-Point Jump
Why Is Merck Stock Trading Higher On Monday?
Express News | Merck Shares up 2% After Therapy for Rare Lung Condition Showed Reduced Risk of Death in Study